Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 1
2019 4
2020 11
2021 28
2022 29
2023 18
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients.
Gervais A, Rovida F, Avanzini MA, Croce S, Marchal A, Lin SC, Ferrari A, Thorball CW, Constant O, Le Voyer T, Philippot Q, Rosain J, Angelini M, Pérez Lorenzo M, Bizien L, Achille C, Trespidi F, Burdino E, Cassaniti I, Lilleri D, Fornara C, Sammartino JC, Cereda D, Marrocu C, Piralla A, Valsecchi C, Ricagno S, Cogo P, Neth O, Marín-Cruz I, Pacenti M, Sinigaglia A, Trevisan M, Volpe A, Marzollo A, Conti F, Lazzarotto T, Pession A, Viale P, Fellay J, Ghirardello S, Aubart M, Ghisetti V, Aiuti A, Jouanguy E, Bastard P, Percivalle E, Baldanti F, Puel A, MacDonald MR, Rice CM, Rossini G, Murray KO, Simonin Y, Nagy A, Barzon L, Abel L, Diamond MS, Cobat A, Zhang SY, Casanova JL, Borghesi A. Gervais A, et al. Among authors: cassaniti i. J Exp Med. 2023 Sep 4;220(9):e20230661. doi: 10.1084/jem.20230661. Epub 2023 Jun 22. J Exp Med. 2023. PMID: 37347462 Free PMC article.
Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs.
Bastard P, Vazquez SE, Liu J, Laurie MT, Wang CY, Gervais A, Le Voyer T, Bizien L, Zamecnik C, Philippot Q, Rosain J, Catherinot E, Willmore A, Mitchell AM, Bair R, Garçon P, Kenney H, Fekkar A, Salagianni M, Poulakou G, Siouti E, Sahanic S, Tancevski I, Weiss G, Nagl L, Manry J, Duvlis S, Arroyo-Sánchez D, Paz Artal E, Rubio L, Perani C, Bezzi M, Sottini A, Quaresima V, Roussel L, Vinh DC, Reyes LF, Garzaro M, Hatipoglu N, Boutboul D, Tandjaoui-Lambiotte Y, Borghesi A, Aliberti A, Cassaniti I, Venet F, Monneret G, Halwani R, Sharif-Askari NS, Danielson J, Burrel S, Morbieu C, Stepanovskyy Y, Bondarenko A, Volokha A, Boyarchuk O, Gagro A, Neuville M, Neven B, Keles S, Hernu R, Bal A, Novelli A, Novelli G, Saker K, Ailioaie O, Antolí A, Jeziorski E, Rocamora-Blanch G, Teixeira C, Delaunay C, Lhuillier M, Le Turnier P, Zhang Y, Mahevas M, Pan-Hammarström Q, Abolhassani H, Bompoil T, Dorgham K; COVID HGE Consortium; French COVID Study Group; COMET Consortium; Gorochov G, Laouenan C, Rodríguez-Gallego C, Ng LFP, Renia L, Pujol A, Belot A, Raffi F, Allende LM, Martinez-Picado J, Ozcelik T, Imberti L, Notarangelo LD, Troya J, Solanich X, Zhang SY, Puel A, Wilson MR, Trouillet-Ass… See abstract for full author list ➔ Bastard P, et al. Among authors: cassaniti i. Sci Immunol. 2023 Dec 22;8(90):eabp8966. doi: 10.1126/sciimmunol.abp8966. Epub 2023 Dec 22. Sci Immunol. 2023. PMID: 35857576 Free PMC article.
The 'hit-and-run' strategy and viral carcinogenesis.
Lasagna A, Cassaniti I, Sacchi P, Figini S, Baldanti F, Bruno R, Pedrazzoli P. Lasagna A, et al. Among authors: cassaniti i. Future Oncol. 2023 Feb;19(5):341-344. doi: 10.2217/fon-2022-1171. Epub 2023 Mar 15. Future Oncol. 2023. PMID: 36919920 No abstract available.
Adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein.
Khan MS, Kim E, McPherson A, Weisel FJ, Huang S, Kenniston TW, Percivalle E, Cassaniti I, Baldanti F, Meisel M, Gambotto A. Khan MS, et al. Among authors: cassaniti i. Antib Ther. 2022 Jul 8;5(3):177-191. doi: 10.1093/abt/tbac015. eCollection 2022 Jul. Antib Ther. 2022. PMID: 35967905 Free PMC article.
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM).
Pedrazzoli P, Lasagna A, Cassaniti I, Piralla A, Squeri A, Bruno R, Sacchi P, Baldanti F, Di Maio M, Beretta GD, Cinieri S, Silvestris N. Pedrazzoli P, et al. Among authors: cassaniti i. ESMO Open. 2023 Jun;8(3):101215. doi: 10.1016/j.esmoop.2023.101215. Epub 2023 Apr 3. ESMO Open. 2023. PMID: 37104930 Free PMC article. Review.
Macrophages and Monocytes: "Trojan Horses" in COVID-19.
Percivalle E, Sammartino JC, Cassaniti I, Arbustini E, Urtis M, Smirnova A, Concardi M, Belgiovine C, Ferrari A, Lilleri D, Piralla A, Baldanti F. Percivalle E, et al. Among authors: cassaniti i. Viruses. 2021 Oct 28;13(11):2178. doi: 10.3390/v13112178. Viruses. 2021. PMID: 34834984 Free PMC article.
Preliminary results on an autochthonous dengue outbreak in Lombardy Region, Italy, August 2023.
Cassaniti I, Ferrari G, Senatore S, Rossetti E, Defilippo F, Maffeo M, Vezzosi L, Campanini G, Sarasini A, Paolucci S, Piralla A, Lelli D, Moreno A, Bonini M, Tirani M, Cerutti L, Paglia S, Regazzetti A, Farioli M, Lavazza A, Faccini M, Rovida F, Cereda D, Baldanti F; Lombardy Dengue network; Lombardy Dengue Network. Cassaniti I, et al. Euro Surveill. 2023 Sep;28(37):2300471. doi: 10.2807/1560-7917.ES.2023.28.37.2300471. Euro Surveill. 2023. PMID: 37707980 Free PMC article.
Immunity to SARS-CoV-2 up to 15 months after infection.
Marcotte H, Piralla A, Zuo F, Du L, Cassaniti I, Wan H, Kumagai-Braesh M, Andréll J, Percivalle E, Sammartino JC, Wang Y, Vlachiotis S, Attevall J, Bergami F, Ferrari A, Colaneri M, Vecchia M, Sambo M, Zuccaro V, Asperges E, Bruno R, Oggionni T, Meloni F, Abolhassani H, Bertoglio F, Schubert M, Calzolai L, Varani L, Hust M, Xue Y, Hammarström L, Baldanti F, Pan-Hammarström Q. Marcotte H, et al. Among authors: cassaniti i. iScience. 2022 Feb 18;25(2):103743. doi: 10.1016/j.isci.2022.103743. Epub 2022 Jan 7. iScience. 2022. PMID: 35018336 Free PMC article.
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages.
Marcotte H, Cao Y, Zuo F, Simonelli L, Sammartino JC, Pedotti M, Sun R, Cassaniti I, Hagbom M, Piralla A, Yang J, Du L, Percivalle E, Bertoglio F, Schubert M, Abolhassani H, Sherina N, Guerra C, Borte S, Rezaei N, Kumagai-Braesch M, Xue Y, Su C, Yan Q, He P, Grönwall C, Klareskog L, Calzolai L, Cavalli A, Wang Q, Robbiani DF, Hust M, Shi Z, Feng L, Svensson L, Chen L, Bao L, Baldanti F, Xiao J, Qin C, Hammarström L, Yang X, Varani L, Xie XS, Pan-Hammarström Q. Marcotte H, et al. Among authors: cassaniti i. Proc Natl Acad Sci U S A. 2024 Jan 16;121(3):e2315354120. doi: 10.1073/pnas.2315354120. Epub 2024 Jan 9. Proc Natl Acad Sci U S A. 2024. PMID: 38194459 Free PMC article.
89 results